Please Wait
Applying Filters...

Information, Expiry & Status of Health Canada Patents covering Atovaquone.

Menu
$ API Ref.Price (USD/KG) : 1,611Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2GlaxoSmithKline Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

Atovaquone

Brand Name : MEPRON

Patent Number : 2152615

Filing Date : 1993-12-23

Strength per Unit : 750 mg / 5ml

Dosage Form : Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-12-23

Date Granted : 2001-10-16

blank

02

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

Atovaquone

Brand Name : MEPRON

Patent Number : 1336266

Filing Date :

Strength per Unit : 250 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-07-11

Date Granted : 1995-07-11

blank